Jacobs Levy Equity Management
ACHV icon

Jacobs Levy Equity Management’s Achieve Life Sciences ACHV Stock Holding History

Jacobs Levy Equity Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-34
Closed -$165K – 789
2015
Q3 		$165K Sell
34
-35
-51% -$211K ﹤0.01% 726
2015
Q2 		$354K Buy
69
+52
+306% +$258K 0.01% 626
2015
Q1 		$82K Sell
17
-43
-72% -$211K ﹤0.01% 752
2014
Q4 		$304K Buy
60
+7
+13% +$34.2K 0.01% 681
2014
Q3 		$310K Buy
+53
New +$368K 0.01% 672
2014
Q2 		– Sell
-9
Closed -$241K – 824
2014
Q1 		$241K Buy
9
+2
+29% +$49.1K ﹤0.01% 789
2013
Q4 		$136K Sell
7
-6
-46% -$105K ﹤0.01% 893
2013
Q3 		$262K Buy
13
+8
+160% +$166K ﹤0.01% 821
2013
Q2 		$105K Buy
+5
New +$112K ﹤0.01% 934

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Jacobs Levy Equity Management's ACHV Position: Q4 2015 in Review

Jacobs Levy Equity Management sold out of Achieve Life Sciences (ACHV) in Q4 2015, closing a stake of 34 shares — an estimated $165K sold.

Jacobs Levy Equity Management first reported a position in ACHV in Q2 2013 and held it in 9 quarters. The position peaked at $354K in Q2 2015. 47 funds tracked by Wall St. Rank hold ACHV as of Q4 2015.

  • Jacobs Levy Equity Management reported no remaining Achieve Life Sciences position as of Q4 2015 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 34 Achieve Life Sciences shares in Q4 2015, an estimated $165K.
  • Jacobs Levy Equity Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 9 quarters.
  • Jacobs Levy Equity Management's Achieve Life Sciences position peaked at $354K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2015, filed 16 Feb 2016.